Study Finds GLP-1s Like Ozempic and Wegovy Do Not Raise Thyroid Cancer Risk

A large study involving over 145,000 patients prescribed GLP-1 medications like Ozempic and Wegovy found no substantial increase in the risk of developing thyroid cancer. The research, published in BMJ, compared the incidence of thyroid cancer among patients taking GLP-1 drugs and those taking other diabetes medications over an average of four years. While the study couldn't rule out a small increase in risk, it provided strong support that GLP-1 analogues are not significantly associated with an elevated risk of thyroid cancer, contradicting some previous findings.